期刊文献+

树突状细胞上巨噬细胞半乳糖型凝集素在乳腺癌细胞识别中的作用研究

Effect study of MGL on dendritic cells in breast cancer cell recognition
下载PDF
导出
摘要 目的:探索乳腺癌细胞系MCF-7与巨噬细胞半乳糖型凝集素(MGL)的结合情况,并对MCF-7细胞表面的MGL配体进行鉴定。方法:采用流式细胞术和单糖抑制实验检测MCF-7细胞表面糖抗原的GalNAc表达以及MGL与MCF-7细胞的结合情况。RT-PCR、Western blot和免疫沉淀等研究方法对MCF-7上MGL配体进行鉴定。结果:MGL能够与乳腺癌细胞MCF-7高度结合,且这种结合是Ca2+依赖的;乳腺癌细胞MCF-7表面高表达GalNAc,即Tn抗原;单糖GalNAc的加入可明显抑制MGL与乳腺癌细胞MCF-7的相互作用;黏蛋白MUC1为乳腺癌细胞系MCF-7表面MGL的配体。结论:黏蛋白MUC1为乳腺癌细胞系MCF-7表面MGL的配体,介导了MGL对乳腺癌细胞的免疫识别。 Objective:To investigate the binding of breast cancer cell line MCF-7 with macrophage galactose lectin(MGL),and to identify the MGL ligand on the surface of MCF-7 cell.Methods:Flow cytometry and monosaccharide inhibition test were used to detect the expression of GalNAc on the surface of MCF-7 cells,and the binding of MGL to MCF-7 cells.The MGL ligands on MCF-7 were identified by RT-PCR,Western blot and immunoprecipitation.Results:MGL could highly bind to MCF-7 cells,and the binding was Ca2+-dependent;the surface of MCF-7 cells highly expressed GalNAc,namely Tn antigen.The addition of monosaccharide GalNAc could significantly inhibit the interaction between MGL and MCF-7.Mucin MUC1 was the ligand of MGL on MCF-7.Conclusion:MUC1 is a ligand of MGL on the surface of MCF-7 cell line and mediates the immune recognition of breast cancer cells by MGL.
作者 卜庆盼 齐文靖 张丽娇 倪秀珍 BU Qing-Pan;QI Wen-Jing;ZHANG Li-Jiao;NI Xiu-Zhen(School of Life Sciences,Changchun Normal University,Changchun 130032,China)
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2021年第2期191-194,200,共5页 Chinese Journal of Immunology
基金 吉林省教育厅“十三五”科学技术项目(JJKH20200825KJ) 长春师范大学自然科学基金项目(2016-001,2019-017)资助。
关键词 乳腺癌细胞 树突状细胞 C-型凝集素 巨噬细胞半乳糖型凝集素 免疫识别 Breast cancer cells Dendritic cells C-type lectin Macrophage galactose lectin Immune recognition
  • 相关文献

参考文献3

二级参考文献24

  • 1Tong Zhou,Yongxi Chen,Li Hao,Yanyun Zhang.DC-SIGN and Immunoregulation[J].Cellular & Molecular Immunology,2006,3(4):279-283. 被引量:11
  • 2Cho HJ ,Bhardwaj N. Against the self: dendritic cells versus cancer. Apmis, 2003, 111(7-8) : 805-817.
  • 3Pinzon-Charry A, Maxwell T, Lopez JA. Dendritic cell dysfunction in cancer: a mechanism for immunosuppression. Immunol Cell Biol, 2005, 83(5) : 451-461.
  • 4Hayashi T, Hideshima T, Akiyama M, et al. Ex vivo induction of multiple myeloma-specific cytotoxic T lymphocytes. Blood, 2003, 102(4) : 1435-1442.
  • 5Bharadwaj U, Li M, Zhang R, et al. Elevated interleukin-6 and GCSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res, 2007, 67 ( 11 ) :5479-5488.
  • 6Yu S, Liu C, Su K, et al. Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J Immunol, 2007, 178 ( 11 ) :6867- 6875.
  • 7Yang WF, Li DT, Li J, et al. The effects of vascular endothelial growth factor on dendritic ceils in esophageal tumor tissue. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 2007,23 ( 1 ) :46-47, 55.
  • 8Gottfried E, Kreutz M, Haffner S, et al. Differentiation of human tumour-associated dendritic ceils into endothelial-like ceils: an alternative pathway of tumour angiogenesis. Scand J Immunol, 2007, 65 (4) :329-335.
  • 9Chen YX, Man K, Ling GS, et al. A Crucial Role for Dendritic Cell (DC) IL-10 in Inhibiting Successful DC-Based Immunotherapy: Superior Antitumor Immunity against Hepatocenular Carcinoma Evoked by DC Devoid of IL-10. J Immunol, 2007, 179(9) :6009- 6015.
  • 10Vicari AP, Treilleux I, Lebecque S. Regulation of the trafficking of tumour-infiltrating dendritic cells by chemokines. Semin Cancer Biol, 2004, 14(3) : 161-169.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部